🇺🇸 FDA

Drug profile · INN

flurbiprofen

FLURBIPROFEN

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

flurbiprofen (FLURBIPROFEN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN flurbiprofen
Brand FLURBIPROFEN
Route ORAL
Formulation TABLET
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 8778391

    Flurbiprofen and muscle relaxant combinations

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8691778

    Flurbiprofen and muscle relaxant gel combinations thereof

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8575170

    Flurbiprofen analogs and methods of use in treating cancer

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is flurbiprofen?

flurbiprofen (FLURBIPROFEN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for flurbiprofen?

FLURBIPROFEN is a marketed brand name for flurbiprofen. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of flurbiprofen?

flurbiprofen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.